Kyowa Kirin Co.,Ltd.

4151 TSE Pharmaceuticals Pharmaceutical
TSE Prime
¥2,191.50
-0.66%
Delayed · cached 15 min

Fair value analysis

4151
Kyowa Kirin Co.,Ltd.
PharmaceuticalsPharmaceutical
¥2,191.50
Close used for this calculation
¥1,909.07Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
59/100
Profitability15/25
Returns7/25
Balance Sheet23/25
Efficiency14/25
Growth6/25
Good
Quality radar
59Prof.15/25Ret.7/25Eff.14/25B.Sht23/25Growth6/25

Consensus fair value

¥1,909.07
Near FV
▼ -12.9% against the close used
Model range ¥498.07 – ¥2,561.40
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear¥498.07Fair value¥1,909.07Bull¥2,561.40
FairClose
52-week traded range
52W low ¥2,164.0052W high ¥2,885.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Kyowa Kirin Co.,Ltd. closed at ¥2,191.50, 14.8% above the consensus fair value of ¥1,909.07 drawn from 9 valuation models.

Financial DNA score 59/100 — Good. P/E of 17.1x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
¥1,921.55
-12.3%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=6.4%, r=10%, tg=3%, n=10yr
Graham Number
¥1,837.66
-16.1%
√(22.5 × EPS × BVPS)
EPS=128.07, BVPS=1171.93 · outside Graham range (P/E 17.1, P/B 1.9) — asset-light, treat as a rough floor
P/E Fair Value
¥2,561.40
+16.9%
EPS × 20x (sector P/E)
EPS=128.07, Sector P/E=20x
Peter Lynch (PEG)
¥817.09
-62.7%
EPS × Growth% (PEG = 1 is fair)
EPS=128.07, g=6.4%
EV/EBITDA
¥2,171.80
-0.9%
(EBITDA × 13.2x − Net Debt) ÷ Shares
EBITDA=86.19B
Dividend Discount (DDM)
¥1,822.55
-16.8%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=62.02, r=10%, g=6.4%
Book Value (P/B)
¥498.07
-77.3%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=1171.93, ROE=7.7%, g=6%, r=10%
Reverse DCF
¥2,191.50
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 5% | Historical: 6.4%
Margin of Safety
¥1,580.15
-27.9%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=2106.87, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.